Gemcitabine, paclitaxel, and cisplatin as induction chemotherapy for patients with biopsy-proven Stage IIIA(N2) nonsmall cell lung carcinoma: a Phase II multicenter study.
about
Evolution of induction chemotherapy for non-small cell lung cancer over the last 30 years: A surgical appraisalRadiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment.Controversies in the management of stage IIIA non-small-cell lung cancer.Before or After: Evolving Neoadjuvant Approaches to Locally Advanced Non-Small Cell Lung Cancer.
P2860
Gemcitabine, paclitaxel, and cisplatin as induction chemotherapy for patients with biopsy-proven Stage IIIA(N2) nonsmall cell lung carcinoma: a Phase II multicenter study.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Gemcitabine, paclitaxel, and c ...... a Phase II multicenter study.
@ast
Gemcitabine, paclitaxel, and c ...... a Phase II multicenter study.
@en
type
label
Gemcitabine, paclitaxel, and c ...... a Phase II multicenter study.
@ast
Gemcitabine, paclitaxel, and c ...... a Phase II multicenter study.
@en
prefLabel
Gemcitabine, paclitaxel, and c ...... a Phase II multicenter study.
@ast
Gemcitabine, paclitaxel, and c ...... a Phase II multicenter study.
@en
P2093
P356
P1433
P1476
Gemcitabine, paclitaxel, and c ...... a Phase II multicenter study.
@en
P2093
Carlo Crispino
Enrico Cortesi
Fabrizio Nelli
Filippo De Marinis
Luigi Brancaccio
Maria Rita Migliorino
Olga Martelli
Stefano Treggiari
P304
P356
10.1002/CNCR.11662
P407
P577
2003-10-01T00:00:00Z